Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- Proexpo Communications LimitedKexing Biopharm's Investigational Anti-TL1A Monoclonal Antibody GB20 Cleared for Clinical Trials in ChinaRecently, Kexing Biopharma (688136.SH) announced that its wholly owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd. ("Shenzhen Kexing"), has received a Notice of Approval for Drug Clinical Trials from China's National Medical Products Administration (NMPA), authorizing the initiation of clinical trials of GB20, a proprietary investigational anti-TL1A monoclonal antibody for inflammatory bowel disease (IBD).Inflammatory bowel...
- Снижение массы тела на 19,3 % к 48-й неделе -- данные исследования фазы III препарата Olatorepatide, двойного селективного агониста ГПП-1/ГИП компании Hansoh, представлены на EASDМИЛАН, 3 октября 2026 г. -- С 28 сентября по 2 октября 2026 года в Милане, Италия, проходит ежегодная конференция ассоциации European Association for the Study of Diabetes (EASD). Разработанный компанией Hansoh Pharma двойной селективный агонист рецепторов глюкагоноподобного...
- VB Health Launches Public Seven-Part Supplement Quality StandardVB Health launches a seven-part supplement quality standard covering research, dosing, sourcing, U.S. manufacturing, testing and transparency.
- Ractigen TherapeuticsRactigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular DystrophyFirst clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. Paired muscle biopsies reveal 3.5- to 5.3-fold increases in sarcolemmal utrophin expression,...
- CVS HealthAetna 2027 Medicare plans offer reliable, affordable access to care & member supportCompanies: CVS HealthPlans designed to provide member value and access to care: $0 copays on Tier 1 drugs and covered vaccines at in-network pharmacies* $0 copays for annual physicals, colonoscopies and mammograms at in-network providers $0 copays for annual Healthy Home Visit from a licensed Signify Health...
- Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. ("Hims" or the "Company")...
- Edelson Lechtzin LLPMillstone Medical Outsourcing Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is ExposedNational class action law firm offers free, confidential case evaluations to individuals whose personal, financial, and health information may have been exposed in the Millstone Medical Outsourcing data breach. NEWTOWN, Pa., Oct. 2, 2026 -- Edelson Lechtzin LLP, a national...
- Edelson Lechtzin LLPAtlantic Digestive Specialists Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is ExposedNational class action law firm offers free, confidential case evaluations to patients whose personal and protected health information may have been exposed in the Atlantic Digestive Specialists data breach. NEWTOWN, Pa., Oct. 2, 2026 -- Edelson Lechtzin LLP, a national class...
- CaseBioscience® schließt sich einem Team an, das von ARPA-H bis zu 7,3 Millionen US-Dollar für die Weiterentwicklung der Lagerung von Zelltherapien bei Raumtemperatur erhältFORT COLLINS, Colorado, 3. Oktober 2026 -- CaseBioscience® gab heute seine Beteiligung an einem multidisziplinären Team unter der Leitung von Likarda bekannt, dem von der Advanced Research Projects Agency for Health (ARPA-H) im Rahmen ihres Programms „BioStabilization...
- Antengene Corporation LimitedAntengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for...
- Resonant Clinical Solutions développe ses activités mondiales dans le domaine des équipements et accessoires médicaux grâce à l'acquisition de LabfishCette acquisition renforce la présence de Resonant en Europe et lui apporte une expertise spécialisée en étalonnage, une couverture IOR/EOR, ainsi que des dépôts partenaires pour accompagner le cycle de vie des essais cliniques à l'échelle mondiale LEESBURG, Virginie, 3 octobre 2026...
- Resonant Clinical Solutions amplía su negocio global de equipos y accesorios con la adquisición de LabfishLa adquisición amplía la presencia de Resonant en Europa e incorpora experiencia especializada en calibración, alcance en IOR/EOR y centros asociados para respaldar el ciclo de vida de los ensayos clínicos a escala mundial LEESBURG, Va., 3 de octubre de 2026 -- Resonant...